Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview

Microbot Medical

Today 24:48

Microbot Medical Inc MBOT.OQ MBOT.O is expected to  show a rise in quarterly revenue when it reports  results on November 10 (estimated) for the period ending September 30 2026
The Hingham Massachusetts-based  company is expected to report revenue of $562.5 thousand, according to the mean estimate from 4 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Microbot Medical Inc is for a loss of 8 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Microbot Medical Inc is $4.00, about 260.4% above its last closing price of $1.11
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Jun. 30 2026
-0.07
-0.08
-0.08
Met
-4.3
Mar. 31 2026
-0.08
-0.08
-0.05
Beat
34.8
Dec. 31 2025
-0.05
-0.06
-0.04
Beat
33.3​
Sep. 30 2025
-0.06
-0.06
-0.07
Missed
-16.7
​​Jun. 30 2025
-0.08
-0.08
-0.10
Missed
-25
Mar. 31 2025
-0.13
-0.13
-0.09
Beat
30.8​
Dec. 31 2024
-0.18
-0.18
-0.20
Missed
-11.1
Sep. 30 2024
-0.17
-0.20
Missed
-17.6
This summary was machine generated November 7 at 00:48 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)